GLAZER CAPITAL, LLC - Jan 30, 2025 Form SCHEDULE 13G Schedule Report for Revance Therapeutics, Inc. (RVNC)

Filing Manager: GLAZER CAPITAL, LLC
Reporting Manager: Glazer Capital, LLC
Security: Revance Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: RVNC
Shares outstanding: 105M shares
Disclosed Ownership: 7.21M shares
Ownership: 6.87%
Form type: SCHEDULE 13G
Date filed: 2/6/2025, 06:19 PM
Date of event: Jan 30, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Glazer Capital, LLC	6.87%	7.21M	0	7.21M	Paul J. Glazer	Paul J. Glazer, Managing Member
Paul J. Glazer	6.87%	7.21M	0	7.21M	Paul J. Glazer	Paul J. Glazer